证券记录 · 已归档季度
CDTX
Cidara Therapeutics, Inc. · Healthcare · Biotechnology
11被追踪持有人
+1Δ持有人
6.12M持有股份
$298.05M报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +10.0% ·
股份流向 +30.0% ·
净新建仓位 +9.1%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q4 2025 | 84 | +2 | 14.72M | $3.25B | +4 | −1 |
| Q3 2025 | 18 | +4 | 8.32M | $797.21M | +4 | — |
| Q2 2025 | 11 | +1 | 6.12M | $298.05M | +2 | −1 |
| Q1 2025 | 7 | +1 | 1.63M | $35.01M | +1 | — |
| Q4 2024 | 6 | +1 | 579.82K | $15.59M | +1 | — |
| Q3 2024 | 4 | +2 | 207.39K | $2.23M | +2 | — |
| Q2 2024 | 2 | — | 138.64K | $1.66M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 1.53M | +1242.0% | $74.43M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 1.11M | — | $53.95M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 1.11M | — | $53.95M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 1.11M | — | $53.95M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 1.11M | — | $53.95M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 1.11M | — | $53.95M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Adage Capital Partners ✦ | 1.10M | +11.1% | $53.58M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | The Vanguard Group ✦ (被动) | 966.71K | — | $47.09M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (被动) | 966.71K | — | $47.09M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 966.71K | — | $47.09M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (被动) | 372.01K | +576.6% | $18.12M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Geode Capital Management ✦ (被动) | 372.01K | +576.6% | $18.12M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 290.95K | +1.1% | $14.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 242.78K | 新增 | $11.83M | 0.0% | New | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 242.78K | 新增 | $11.83M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 242.78K | 新增 | $11.83M | 0.0% | New | 1 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (被动) | 236.94K | +949.5% | $11.54M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 156.78K | +69.5% | $7.64M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Fidelity (FMR) ✦ | 108.72K | — | $5.30M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 8.40K | 新增 | $410,000 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $11.83M | 0.0% |
| Marshall Wace | $11.83M | 0.0% |
| Marshall Wace | $11.83M | 0.0% |
| T. Rowe Price | $410,000 | 0.0% |
已清仓
| Millennium Management | $1.37M | 曾为 0.0% |
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据